Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: AN2 Therapeutics Inc., 3 years.
AN2 Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AN2 Therapeutics Inc. June 3, 202677.4%
-
AN2 Therapeutics Inc. June 7, 202395.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | AN2 Therapeutics Inc. | Grant or award | +2,852 | — | — |
| Apr 10, 2026 | AN2 Therapeutics Inc. | Grant or award | +3,775 | — | — |
| Jan 12, 2026 | AN2 Therapeutics Inc. | Grant or award | +11,560 | — | — |
| Oct 10, 2025 | AN2 Therapeutics Inc. | Grant or award | +10,367 | — | — |
| Jul 10, 2025 | AN2 Therapeutics Inc. | Grant or award | +11,875 | — | — |
| Apr 10, 2025 | AN2 Therapeutics Inc. | Grant or award | +9,705 | — | — |
| Dec 19, 2024 | AN2 Therapeutics Inc. | Grant or award | +8,972 | — | — |
| Jan 16, 2024 | AN2 Therapeutics Inc. | Open-market sale | −84,093 | $19.65 | $1,652,427 |
| Jan 16, 2024 | AN2 Therapeutics Inc. | Open-market sale | −15,907 | $19.65 | $312,573 |
| Nov 14, 2023 | AN2 Therapeutics Inc. | Open-market sale | −1,522 | $16.15 | $24,580 |
| Nov 14, 2023 | AN2 Therapeutics Inc. | Open-market sale | −288 | $16.15 | $4,651 |
| Oct 2, 2023 | AN2 Therapeutics Inc. | Open-market sale | −4,770 | $16.07 | $76,654 |
| Oct 2, 2023 | AN2 Therapeutics Inc. | Open-market sale | −902 | $16.07 | $14,495 |
| Sep 29, 2023 | AN2 Therapeutics Inc. | Open-market sale | −83,337 | $16.28 | $1,356,726 |
| Sep 29, 2023 | AN2 Therapeutics Inc. | Open-market sale | −15,764 | $16.28 | $256,638 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.